FPH.NZ
FPH.NZ
NZFAPE0001S2
Fisher & Paykel Healthcare Corp
Loading chart...

Company Profile

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, the company provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP), and nasal high flow products. Further, it offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Related stocks

LENSKART.NS
LENSKART.NS • India
LENSKART SOLUTIONS LTD
677.65 INR
12.13B USD
7741.T
7741.T • Japan
HOYA CORP
25,055 JPY
52.81B USD 1Y +12.7%
688301.SS
688301.SS • China
IRAY GROUP
79.99 CNY
3.75B USD 1Y -9.8%
7747.T
7747.T • Japan
ASAHI INTECC CO LTD
3,363 JPY
5.64B USD 1Y +42.6%
300896.SZ
300896.SZ • China
IMEIK
95.03 CNY
4.3B USD 1Y -47.3%
603087.SS
603087.SS • China
GAN&LEE PHARMACEUTICALS CO LTD
75.52 CNY
6.76B USD 1Y -0.2%
ANN.AX
ANN.AX • Australia
ANSELL FPO [ANN]
45.14 AUD
4.44B USD 1Y +37.4%
603301.SS
603301.SS • China
ZHENDE MEDICAL CO LTD
81 CNY
3.2B USD 1Y +57.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
27.9% p.a.
Max Drawdown (5Y)
-46.4%
Sharpe Ratio (5Y)
0.27
Beta Factor
0.88
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 59.6 (Elevated multiple compression risk)
Historical Stress Test: Maximum peak-to-trough drawdown of -52.0% in the extended horizon.
ende